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Background: Hip fracture patients experience high morbidity and mortality rates in the first post-operative year
after discharge. We compared mortality, utilization, costs, pain and function between two prospective cohorts of
hip fracture patients, both managed with identical perioperative protocols and one group subsequently managed
via a “Patient-Centered Medical Home” (PCMH) primary care management model.
Methods: We analyzed 6 and 12-month outcomes from two matched cohorts of patients who were surgically
treated for hip fracture from January 1, 2010 to June 30, 2011 at two hospitals (n = 194). Controls did not receive
PCMH and were matched to cases on surgery date, sex, age, and comorbidities. Mortality and healthcare utilization
were the primary outcomes studied, with medical costs, quality of life, pain and function at 12 months assessed as
secondary outcomes in a subgroup. Survival analysis, regression and Student-t testing were used with p < 0.05
considered significant.
Results: At 6 months, PCMH patients had significantly lower mortality than patients receiving standard care
(11% vs. 26%, p < 0.01). At 12 months, a difference persisted (23% vs. 30%, p = 0.12) but was no longer statistically
significant. Mean quality of life scores were similar (0.73 vs. 0.76, p = 0.49) and Harris Hip score was slightly
improved for PCMH (73 vs. 64, p = 0.04). Mean costs per patient per month were lower for PCMH but not
significantly different ($69 vs. $141, p = 0.20 for pharmacy costs; $1212 vs. $1452, p = 0.45 for non-pharmacy costs).
Conclusions: Patients receiving aggressive post-discharge care from a PCMH program showed significant benefits
in terms of reduced mortality at 6 months, with similar costs and functional outcomes at 12 months. PCMH was
not shown to improve all outcomes studied, but these results suggest that ongoing Medical Home management
can have some benefit for patients without negatively impacting function or cost.
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Hip fractures remain a major challenge to health care
systems throughout the world [1], as both the number of
hip fracture patients and the costs associated with their
care increase over time [2-6]. Despite improvements in
implant technology, morbidity and mortality rates in the
first postoperative year remain high [7]. Numerous reports* Correspondence: jhgraham1@geisinger.edu
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unless otherwise stated.have shown that perioperative approaches that include
medical optimization, multidisciplinary care and rehabili-
tation decrease immediate perioperative morbidity [8].
However, the significant morbidities and costs associated
with hip fractures more often occur after discharge and
are related to long-term management of medical comor-
bidities [9]. Further complicating matters, it is difficult to
distinguish between morbidity related to the hip fracture
itself as opposed to the overall frailty and vulnerability
of the elderly population [10]. In theory, an optimal
approach to managing patients would initially optimizel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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tients’ functional condition, and subsequently manage
the patient’s overall health status including existing co-
morbidities. This multimodal approach has not been
previously reported in the orthopaedic literature. If this
approach successfully decreased readmissions and mortal-
ity, any increased costs associated with more aggressive
post-operative management might be offset within a health
system [11].
At the same time that hip fractures challenge the
orthopaedic community, there are recognized shortcom-
ings in hospital post-discharge transitions of care in gen-
eral. As recently as 2009, half of Medicare fee-for-service
patients who had a 30-day readmission did not visit their
physician before being readmitted [12]. Communication
gaps are suspected to account for a significant share of
readmissions, and these occur between providers (e.g.,
discontinued prescriptions), between provider and patient
(e.g., lack of patient education) and in transitions between
the hospital and community setting [13-15]. Systematic
reviews have reported significant reductions in 30-day
readmission rates and cost savings associated with several
enhanced discharge processes, most of which used enhan-
ced in-hospital communication, payment incentives, and
other multimodal approaches [16-18].
The Patient-Centered Medical Home (PCMH) model,
which evolved from the Chronic Care Model [19],
involves enhancing the role of primary care providers as
the locus of care coordination. The PCMH is not a phy-
sical location, but a redesign of healthcare delivery to
facilitate partnerships among an individual patient and
his/her personal physician and family, all supported by
resources including enhanced information systems and
communications infrastructure. The American Academy
of Pediatrics (AAP), American Academy of Family Physi-
cians (AAFP), and other societies representing approxi-
mately 330,000 U.S. physicians describe 7 joint principles
of the PCMH. These principles include each patient
having an ongoing relationship with his/her personal
physician, highly coordinated care, enhanced access to
care, and payment structures that reflect the value of care
management work [20]. At our health system, a PCMH
model attempts to reduce post-discharge morbidity by
using nurse case managers to coordinate the transition
from hospital to home. Case managers use early telephone
outreach, medication reconciliation, social support assist-
ance, and ensure timely follow-up with primary care physi-
cians in the month immediately following surgery.
We compared rates of mortality, hospitalizations, emer-
gency department visits and prescription orders between
two prospective cohorts of hip fracture patients, both
managed with identical perioperative protocols and
one group subsequently managed via PCMH. Costs,
functional outcomes and quality of life were also studiedas secondary outcomes in a smaller subsample. We hy-
pothesized that the best outcomes would occur in patients
managed initially with a standardized approach and subse-
quently with PCMH management.
Methods
Setting
This was a prospective, non-randomized two-cohort
study conducted at two level-1 trauma centers within
Geisinger Health System (GHS), a large integrated health
system located in Pennsylvania. GHS serves a 41-county
area with approximately 2.5 million people, employs a
total of 800 physicians including 200 primary care physi-
cians, and operates 41 outpatient clinics and five hospitals.
The average duration of care for patients in the system
exceeds ten years, and an electronic health record has
been the sole-source ambulatory record for all patients
since 2001. The Department of Orthopaedics also main-
tains a prospective trauma registry in which all treated
fractures are recorded and classified according to the AO/
Orthopaedic Trauma Association (AO/OTA) radiographic
system.
Beginning in 2006, GHS implemented a “Patient-
Centered Medical Home” (PCMH) program, referred to
as “ProvenHealth Navigator®”. This program has been
described in detail elsewhere [21,22]. This PCMH model
represents a partnership between the health system and
an affiliated insurance provider (Geisinger Health Plan)
and is comprised of several parallel initiatives to improve
overall quality of care. The primary element of interest
for this study is that office-based nurse case managers
(CMs) are hired by the insurance provider and inte-
grated into the clinical care team at specific primary care
sites. These CMs focus on coordinating services for at-risk
patients who belong to that clinic, and they provide early
outreach and close follow-up for patients who are transi-
tioning home after a hospital discharge for any reason in-
cluding hip fracture surgery [23]. Quality measurement and
reporting encourage adherence to evidence-based care
guidelines, and practices and individual physicians are paid
additional stipends and can share in estimated savings,
subject to meeting quality goals. No additional stipends at
any site were tied directly to this particular study.
During the transition period of 2006–2011, the PCMH
program was introduced to 41 clinic sites in phases.
Although the order of site enrollment was not random-
ized, clinic sites were geographically dispersed and neither
individual physicians nor patients could choose whether
to participate in the PCMH program. Thus, the transition
period provided an opportunity for a natural experiment
to examine clinical outcomes of patients undergoing hip
fracture surgery who could be categorized as either
PCMH or non-PCMH according to the clinical site
where their primary care physician was located. This
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Board (IRB).
Study population
All patients aged 60 or over who presented to either of
two hospitals with an isolated closed, acute proximal
femur fracture and were surgically treated from January 1,
2010 to June 30, 2011 were enrolled in this study. Acute
fractures were defined as fractures sustained within 48
hours prior to presentation, and proximal femur frac-
tures were defined as fractures diagnosed by plain
radiography and classified as AO/OTA fractures 31-A
(trochanteric) or 31-B (neck) by the attending surgeon
on call. Patients were excluded if they sustained frac-
tures that were open, high energy, related to osteomye-
litis or neoplastic disease, or radiographically occult.
Patients were also excluded if they presented in a mori-
bund state, where any consideration of surgical treat-
ment was deemed inappropriate, or if they elected to be
treated non-operatively.
All patients received preoperative and perioperative
care according to defined protocols that were jointly
established by the two hospitals prior to the study
(Table 1). After discharge, patients whose primary care
physician belonged to a clinic site in the PCMH program
were categorized as the “PCMH group”. These patients
received follow-up care from a nurse case manager
including: telephone follow-up within 48 hours; medication
management (reconciliation and review of medications,
timing and doses); home safety assessment; development of
an action plan including who to notify about concerns; as-
sistance with social supports and rehabilitation services
(if necessary); weekly phone calls from an automated voice
response system to inquire about adverse effects; additional





1. Perioperative risk assessment
and management
1. Follow-up with High-Risk Oste
Clinic (if needed)
2. Timing of surgical intervention 2. Continuation of aggressive ph
3. Prophylactic antibiotics
4. Thromboembolic prophylaxis 3. Deep venous thrombosis (DVT
5. Prevention and management
of delirium
4. Wound check, functional evalu
and radiographic examination
6. Prevention of decubitus ulcers
7. Prevention of Constipation
8. Physical therapy intervention 5. Periodic assessment (no less th
until a baseline functional state
9. Assessment for underlying osteoporosis
10. Appropriate discharge placementfollow-up visit for the patient and family with the primary
care physician and nurse case manager within 7 days. Pa-
tients whose primary care physician did not belong to an
active PCMH site were categorized as “control” patients
and received usual care.
Data were extracted from the electronic health rec-
ord and insurance claims databases to record all
deaths, hospitalizations, emergency department visits,
and prescription orders during the 12 months follow-
ing surgery. The health system receives monthly updates
on mortality from Social Security for all patients, even
those who no longer actively seek care in the system, so
data on mortality is known to be 100% complete. For a
secondary analysis of cost outcomes, we extracted insur-
ance claims information on the subset of patients with a
specific insurance provider (Geisinger). In addition, pa-
tients surviving at 12 months were contacted by tele-
phone and asked to complete a quality-of-life (EQ-5D, or
EuroQOL) questionnaire and the pain/function subsec-
tion of the Harris Hip Score questionnaire (Table 2)
[24,25].
Statistical analysis
The primary endpoint for this study was all-cause mor-
tality following hip fracture surgery, and so we used
nonparametric survival analysis to compare survival be-
tween the two cohorts at 6 and 12 months. Secondary
endpoints were rates of inpatient hospitalizations, emer-
gency department visits, and prescription orders during
the 6 and 12 months following surgery, which were
compared using Poisson regression. Finally, as tertiary
endpoints, we used Student-t testing to compare mean
medical costs (pharmacy, non-pharmacy and total) at 6
and 12 months, and questionnaire scores among re-
sponders at 12 months. Costs were normalized to set theol for all patients in the study
Medical home management
(Patient-Centered Medical Home patients only)
oporosis 1. Nurse Case Manager (CM) makes initial call to
patient within 24–48 hours of hospital discharge.
ysical therapy
) Prophylaxis 2. CM reviews medication list with patient.
ation,
at 6 weeks
3. CM ensures that follow-up visit is scheduled
with primary care provider within 7 days.
an every 3 months)
or death occurs
4. CM ensures that a patient-specific action plan is
in case if patients have any trouble.
5. Patients receive weekly calls (2–3 minutes) for
4 weeks, to ask about complications or areas
that need follow-up from CM.
Table 2 Questions asked via telephone questionnaire to surviving patients at 12 months follow-up
EQ-5D quality-of-Life (EuroQOL) index questions (respondent chooses one answer) Harris hip score pain/function subsection
(response choices not shown)
1. Mobility 1. Pain
I have no problems in walking about. How would you describe your hip pain?
I have some problems in walking about.
I am confined to bed.
2. Self-care 2. Support
I have no problems with self-care. How much support do you need when walking?
I have some problems washing or dressing myself.
I am unable to wash or dress myself. 3. Distance Walked
3. Usual activities How much are you able to walk?
I have no problems with performing my usual activities.
I have some problems with performing my usual activities.
I am unable to perform my usual activities. 4. Limp
Do you walk with a limp?4. Pain/Discomfort
I have no pain or discomfort. 5. Shoes/Socks
I have moderate pain or discomfort. Are you able to put on your own shoes and socks?
I have extreme pain or discomfort.
5. Anxiety/Depression 6. Stairs
I am not anxious or depressed. Are you able to climb stairs?
I am moderately anxious or depressed. 7. Public transportation
I am extremely anxious or depressed. Are you able to board a bus?
6. Quality-of-life scale question 8. Sitting
To help people say how good or bad a health state is, imagine a scale on which the
best state you can imagine is marked 100 and the worst state you can imagine is marked 0.
We would like you to indicate on this scale how good or bad your own health is today,
in your opinion.
Are you able to sit comfortably?
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order to protect business-sensitive information. For all
analyses, generalized estimating equation (GEE) methods
were used to cluster observations to account for the
matching of subjects described below. All statistical ana-
lysis was performed using SAS software (SAS 9.2, Cary,
NC) with differences at p < 0.05 considered statistically
significant.
This study was non-randomized, and although PCMH
assignment depended only on the geography of the clinic
sites and not individual patient/physician preference, we
recognized there could still be unbalanced confounding
variables in the two groups. We therefore limited the
analyses to a matched set of cases and controls. Each
PCMH patient (case) was matched to one non-PCMH
patient (control) based on surgery date (±90 days) and a
propensity score to adjust for disease severity following
the methods of Rosenbaum and Rubin [26,27]. A logistic
regression model calculated each patient’s propensity
score (i.e., propensity for belonging to the PCMH group,
on a scale of 0–1) using sex, age, Charlson ComorbidityIndex, number of admissions and emergency department
visits during the 12 months prior to surgery, and history of
10 comorbidities (hypertension, stroke, myocardial infarc-
tion, congestive heart failure, chronic kidney disease, other
fractures, osteoporosis, anemia Alzheimer’s disease, and
cancer). PCMH patients were excluded from analysis if
they had propensity scores that did not overlap with any
control patients, and cases were only matched to controls
whose propensity scores fell within a tight caliper range in
order to ensure balance between the cohorts [28]. This
matching procedure was performed on the entire study
population to generate two matched cohorts for analysis of
mortality/utilization outcomes (for which all subjects had
available data), and then repeated to generate matched
subgroups for cost (where only some patients had claims
data) and functional outcomes (where only a subset of
patients had survey responses at 12 months). Because of
our strict inclusion/exclusion criteria limiting the study
only to patients with a specific fracture type and operative
treatment, further details of the fracture type or surgery
were not used for matching.
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A total of 303 hip fracture patients met eligibility criteria
for the study during the enrollment period, 108 of whom
received PCMH post-discharge care and 195 of whom
did not. The mean age was 81 years (range 60–100), and
two-thirds (201 of 303) of patients were female. The
overall survival rate at 12 months for this entire popu-
lation was 219/303 (72%). After matching cases with
controls, eleven PCMH patients had to be excluded for
insufficient matches, resulting in a final study cohort of
97 PCMH cases matched to 97 non-PCMH controls. In
the matched set, the mean age was 82 years (range 76–89)
and 142/194 (73%) were female. Table 3 presents all
baseline characteristics of the two primary matched
cohorts (n = 194) for comparison.
For the secondary analysis of healthcare costs, claims
data were available for 66/108 (61%) of the PCMH
patients and 42/195 (21%) of the non-PCMH patients.
For the quality-of-life and pain/function telephone ques-
tionnaires administered to non-deceased patients at 12
months, the survey response rate was 41/82 (50%) for
PCMH patients and 50/137 (37%) for non-PCMH pa-
tients. Repeating the matching procedure for the analysis
of secondary outcomes yielded 15 matched pairs with cost
data who survived 12 months (n = 30), and 35 matched
pairs with pain/function data who survived 12 months
(n = 70).
Table 4 presents a summary of all outcomes at 6 and
12 months after surgery. At 6 months post-operatively,
patients receiving PCMH post-discharge management
had a significantly lower mortality rate than patients re-
ceiving standard care (11 vs. 26% respectively, p < 0.01). At
12 months, a difference persisted (23 vs. 30%, p = 0.12),
though it was no longer statistically significant. Figure 1Table 3 Baseline characteristics of the case and control






Age at surgery in years, Mean (SD) 82 (9) 82 (9)
% Male 28 26
Charlson comorbidity index, Mean (SD) 2.4 (2.1) 2.3 (2.2)
% Hypertension 76 78
% Stroke 19 14
% AMI 36 37
% Heart failure 22 22
% CVD 20 20
% Renal disease 28 29
% Diabetes 26 26
% Cancer 32 25
% Alzheimer’s 15 19presents the all-cause mortality survival curves for these
two cohorts. The mean Harris Hip Pain/Function Score
was also significantly improved at 12 months in the PCMH
group as compared to controls (73 vs. 64, p = 0.04). Other-
wise, no differences between the cohorts reached statistical
significance. Differences in numbers of all-cause hospitali-
zations, ED visits and prescription orders per patient were
not significantly different at 6 months (p = 0.69-0.91) or 12
months (p = 0.16-0.83). The mean EQ-5D quality-of-life
index was similar between the two groups (0.73 vs. 0.76,
p = 0.49), as was the mean EQ-5D Scale. For those
patients surviving 6 months, mean pharmacy and non-
pharmacy costs were lower in the PCMH cohort but not
significantly so (p = 0.27-0.95), and a similar trend per-
sisted at 12 months (p = 0.20-0.45).
Discussion
Our study demonstrates, in a prospective study of
patients receiving a unified in-hospital protocol, that the
addition of post-discharge care from a “Patient-Centered
Medical Home” program, including a nurse case man-
ager for primary care-based follow-up, was successful in
significantly reducing mortality in the 6 months follow-
ing hip fracture and showed evidence of benefits to hip
pain and function as well. While it may be unrealistic to
expect that such a post-discharge program would elim-
inate mortality/morbidity, this study makes a promising
case for utilizing PCMH programs for a focused, limited
period following discharge. Although significant benefits
in reduced admissions, emergency department visits or
medication utilization and costs were not seen, the two
cohorts remained similar in these respects, suggesting
that the aggressive follow-up by the PCMH program did
not substantially drive up healthcare utilization or costs.
Future larger-scale studies should help to better define
the optimal patient population for such programs and
refinements that would provide further benefits for
patients undergoing hip fracture surgery. We note that,
while we found more published estimates of 1-year
mortality than 6-month mortality, our control group's
6-month and 12-month mortality rates of 26 and
30%, respectively, appear to be consistently in the range of
the published findings of Johnston et al. [29] and others
who have followed operative treatment of hip fractures.
Mortality and morbidity after hip fracture in elderly
patients remains a serious problem; however, there is
growing evidence to suggest that patient factors and spe-
cific details of the approach to post-fracture treatment
can impact mortality and quality of life. As noted by
Johnston et al., many studies report mortality following
hip fracture as a simple percentage and do not take into
account age, gender and other factors [29]. In a recent
systematic review, Butler et al. concluded that while nei-
ther implant type nor surgical approach were associated
Table 4 Outcomes at 6 and 12 months for the two cohorts, including mortality, hospitalizations, emergency
department (ED) visits, prescription orders, and costs, with significant differences in bold
Medical home cases Controls p-values
Mortality
N, subjects per group 97 97 --
N, Deaths at 6 months (%) 11 (11%) 25 (26%) <0.01
N, Deaths at 12 months (%) 22 (23%) 29 (30%) 0.12
Healthcare utilization
N, matched subjects per group 97 97 --
Hospitalizations per 100 patients at 6 months 12.4 13.4 0.84
ED visits per 100 patients at 6 months 35.1 34.0 0.91
Prescription orders per patient at 6 months 34.0 31.6 0.69
Hospitalizations per 100 patients at 12 months 23.2 25.7 0.83
ED visits per 100 patients at 12 months 69.6 54.3 0.42
Prescription orders per patient at 12 months 56.5 40.2 0.16
Healthcare costs†
N, matched subjects per group 15 15 --
Mean pharmacy costs per patient-month (0–6 months) $100 $175 0.27
Mean non-pharmacy costs per patient-month (0–6 months) $3,527 $3,572 0.95
Mean total costs per patient-month (0–6 months) $3,627 $3,509 0.89
Mean pharmacy costs per patient-month (0–12 months) $69 $141 0.20
Mean non-pharmacy costs per patient-month (0–12 months) $1,212 $1,452 0.45
Mean total costs per patient-month (0–12 months) $1,281 $1,496 0.52
Quality of life and function at 12 months
N, matched subjects per group 35 35 –
Mean EQ-5D index* 0.76 0.73 0.49
Mean EQ-5D QOL scale** 72 72 0.99
Harris hip pain/Function score^ 73 64 0.04
Sample sizes differ among outcomes because of availability of cost, questionnaire data, and questionnaire outcomes were assessed only at 12 months.
*EQ-5D Index is on a scale of 0–1 with 1 = best.
**EQ-5D QOL Scale is on a scale of 0–100 with 100 = best.
^Harris Hip pain/function score is on a scale of 0–91 with 91 = best.
†All costs have been normalized such that pharmacy costs (0–6 months) for the MH group = $100.
Figure 1 All-cause mortality survival curves for “Patient-Centered
Medical Home” (PCMH) and control cohorts. Dashed lines around
each curve represent 95% confidence intervals.
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age, sex, pre-fracture functioning, and cognitive im-
pairment were directly related to mortality and functional
outcomes [30]. This literature suggested that the main
mortality risk for elderly women is in the 6 weeks fol-
lowing surgery, while the risk for men is higher near 6
months, with comorbidities and age impacting different
subgroups. In a study that complements our current
results in a different population, Rahme et al. retrospect-
ively reviewed 11,326 patients receiving hemiarthroplasty
for hip fracture and showed that the small percentage of
those (16%) who received post-discharge home care had a
lower mortality rate at 3 months than those who received
no home care [31]. While the data collected for this study
do not allow us to pinpoint the exact reason why the
PCMH program influenced the 6-month mortality rate in
our study, we believe that by providing reinforcement
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mary care PCMH team may be able to better engage, acti-
vate and educate patients as well as identify and resolve
issues that may otherwise be missed or caused by care
gaps during the transition from hospital to home.
The main strengths of our study are its population and
statistical design. We were able to use patients in an in-
tegrated health system where electronic health records
were available for the hip fracture population to quantify
mortality, inpatient admissions, emergency department
visits and other healthcare utilization. Furthermore, we
were able to take advantage of the fact that a PCMH
program was in the middle of being implemented such
that patients would naturally be assigned to either an
intervention group (PCMH) or control group for post-
discharge care. Finally, we employed robust statistical
methods to identify and balance confounding variables
in the two cohorts through matching. The chief limita-
tions of the study are the modest sample size and the
fact that it was a non-randomized study, though we took
steps to address biases due to confounding through the
matched study design. Nevertheless, not all subjects
could be appropriately matched to controls, resulting in
a further reduced sample size. We note, for example,
that the number of deaths between 6 and 12 months
was small, and with a larger sample size, some of the
nonsignificant findings here may also have reached stat-
istical significance. For the secondary outcomes of cost
and functional questionnaires, we also note that not all
subjects responded to the telephone questionnaire or
had the appropriate insurance provider that allowed us
to measure costs. Finally, the questionnaires were ad-
ministered at 12 months only and we did not collect
preoperative scores, though we expect that acute injury
patients would have both EQ-5D and functional scores
similar to the general population in their own age range,
on average. While we took advantage of the data
collection methods of an integrated health system (EHR
tracking, claims data, survey center) to perform this inves-
tigation, we note that standardized protocols and PCMH
models are increasingly being adopted across the U.S. and
we believe that these results should be highly translatable
to a variety of healthcare settings.
Increasingly, society, patients and payors are demand-
ing measurable quality outcomes. The biggest social im-
pacts may be made by improving the outcome of patient
groups whose injuries significantly affect society, such as
the elderly patients who sustain hip fractures. Given the
multitude of different implant studies which have shown
little difference in one-year outcomes for this common
yet socially-disruptive injury, studies like this one sug-
gest that the patient care that takes place outside the
operating room may ultimately have the biggest impact
on improved outcomes. The biggest improvements thusfar in hip fracture care have not come from changes in im-
plant technology (e.g., switching to a locked side plate or
to an intramedullary device) [30], but from multidisciplin-
ary management of these patients in the acute setting;
longer-term benefits of these in-hospital interventions,
however, have not been widely demonstrated [32-34]. It is
our hope that the current study provides new evidence
regarding important patient outcomes and costs, compar-
ing an intrinsic control group with an experimental group,
and that future work will support compelling arguments
to government and private payors that the most
cost-effective standard of care also gives the highest
quality outcome. We recognize that the majority of
care-coordination efforts thus far have focused on chronic
diseases such as congestive heart failure or diabetes, and
that evidence of effectiveness has been mixed, depending
on the specific features of the intervention [35-38]. Future
work should determine which specific conditions yield
high-value results in order to avoid the error of a one-
size-fits-all approach.
Conclusion
Patients receiving aggressive post-discharge care from a
“Patient-Centered Medical Home” program showed sig-
nificant benefits in terms of reduced mortality, improved
function, and trends toward reduced medical costs in
the time period following hip fracture. Future studies
with larger cohorts of PCMH patients are highly encour-
aged in order to reinforce these results and further
examine the details of how PCMH may or may not
benefit individual patients. Post-surgical care of elderly,
multi-comorbid patients is complex, but these results
suggest that ongoing PCMH management can benefit
patients in the critical period immediately following a
hip fracture and surgery.
Consent
A HIPAA waiver of authorization and consent was
granted for the retrospective review of records for this
study. A partial waiver of authorization and consent was
granted for prospectively identifying patients for follow-up
questionnaires over the telephone, and completing the
telephone survey implied verbal consent on part of the
patient.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JHG contributed in the study concept and design, data analysis, and
preparation of the manuscript. TRB contributed in the study concept and
design and preparation of the manuscript. KAS contributed in the data
collection and preparation of the manuscript. KI contributed in the
preparation of the manuscript and critical review. WRS contributed in the
study concept and design, preparation of the manuscript, and critical review.
All authors read and approved the final manuscript.
Graham et al. Patient Safety in Surgery 2014, 8:7 Page 8 of 8
http://www.pssjournal.com/content/8/1/7Acknowledgments
This project was funded by a 2010 grant from the Orthopedic Trauma
Association. The authors would also like to thank: Janet Tomcavage and her
team at Geisinger Health Plan for consultation, planning and acquisition of
claims data; and David Nevius and the Geisinger Survey Call Center team for
administration of the telephone surveys. Earlier versions of this work were
presented at the annual conferences of the Orthopaedic Trauma Association
(OTA) in Minnesota, MN, October 3–6, 2012 and the American Academy of
Orthopedic Surgeons (AAOS) in Chicago, IL, March 19–23, 2013.
Author details
1Geisinger Center for Health Research, 100 N. Academy Ave., Danville
PA 17822, USA. 2Department of Orthopedics, Geisinger Health System,
Danville, PA, USA. 3Mountain Orthopaedic Trauma Surgeons at Swedish,
Englewood, CO, USA.
Received: 4 December 2013 Accepted: 22 January 2014
Published: 3 February 2014References
1. Johnell O, Kanis A: An estimate of the worldwide prevalence, mortality
and disability associated with hip fracture. Osteoporos Int 2004,
15:897–902.
2. Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C: Excess mortality
following hip fracture: a systematic epidemiological review.
Osteoporos Int 2009, 20:1633–1650.
3. Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF: The
aftermath of hip fracture: discharge placement, functional status change,
and mortality. Am J Epidemiol 2009, 170:1290–1299.
4. Brauer CA, Cocaperraillon M, Cutler DM, Rosen AB: Incidence and mortality
of hip fractures in the United States. JAMA 2009, 302:1573–1579.
5. Haentjens P, Magaziner J, Colonemeric CS, Vanderscheuren D, Milisin K,
Velkeniers B: Excess mortality after hip fracture among older women
and men. Ann Intern Med 2010, 152:380–390.
6. Haleem S, Lutchman L, Mayahi R, Grice JE, Parker MJ: Mortality following
hip fracture: trends and geographical variations over the last 40 years.
Injury Int J Care Injured 2008, 39:1157–1163.
7. Richmond J, Aharonoff GB, Zuckerman JD, Koval KJ: Mortality risk after hip
fracture. J Orthop Trauma 2003, 17:53–56.
8. Andersen RM: Revisiting the behavioral model and access to medical
care: does it matter? J Health Soc Behav 1995, 36:1–10.
9. Roche JJ, Wenn RT, Sahota O, Moran CG: Effect of comorbidities and
postoperative complications on mortality after hip fracture in
elderly people: prospective observational cohort study. BMJ 2005,
331:1374–1379.
10. Robbins JA, Biggs ML, Cauley J: Adjusted mortality after hip fracture: from
the cardiovascular health study. J Am Geriatr Soc 2006, 54:1885–1891.
11. Maeng DD, Graham J, Graf TR, Liberman JN: Reducing long-term cost by
transforming primary care: evidence from Geisinger’s medical home
model. Am J Manag Care 2012, 18:149–155.
12. Jencks SF, Williams MV, Coleman EA: Rehospitalizations among
patients in the Medicare fee-for-service program. N Engl J Med 2009,
360:1418–1428.
13. California HealthCare Foundation: Uncoordinated Care: A Survey of Physician
and Patient Experience. Oakland, CA: California HealthCare Foundation; 2007.
14. Brown R: The Promise of Care Coordination: Models that Decrease
Hospitalizations and Improve Outcomes for Medicare Beneficiaries with Chronic
Illnesses, A Report Commissioned by the National Coalition on Care
Coordination (N3C). Princeton, NJ: Mathematica Policy Research, Inc; 2009.
15. Schoen C, Osborn R, How SKH, Doty M, Peugh J: In chronic condition:
experiences of patients with complex health care needs, in eight
countries. Health Affairs 2008, 28(1):w1-16, 2009.
16. Shepperd S, McClaren J, Phillips CO, et al: Discharge planning from
hospital to home. Cochrane Database Syst Rev 2010, 1:CD000313.
17. Jack BW, Chetty VK, Anthony D, et al: A reengineered hospital discharge
program to decrease rehospitalizations: a randomized trial. Ann Intern
Med 2009, 150:178–187.
18. Menninger B: Reinventing Healthcare Delivery: Innovation and Improvement
behind the Scenes. Oakland, CA: California Healthcare Foundation Issue Brief
[serial online]; 2009.19. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi AE:
Improving chronic illness care: translating evidence into action. Health
Aff 2001, 20:64–78.
20. American College of Physicians (ACP): Joint principles of the patient-
centered medical home. http://www.aafp.org/dam/AAFP/documents/
practice_management/pcmh/initiatives/PCMHJoint.pdf.
21. Gilfillan RJ, Tomcavage J, Rosenthal MB, et al: Value and the Medical
Home: Effects of Transformed Primary Care. Am J Manage Care 2010,
16:607–614.
22. Steele GD, Haynes JA, Davis DE, et al: How Geisinger's advanced medical
home model argues the case for rapid-cycle innovation. Health Aff 2010,
29:2047–2053.
23. Graham J, Tomcavage J, Salek DM, Sciandra J, Davis DE, Stewart WF:
Post-discharge monitoring using interactive voice response system
reduces 30-day readmission rates in a case-managed Medicare
population. Med Care 2012, 50:50–57.
24. Szende A, Williams A: Measuring Self-Reported Population Health: An
International Perspective Based on EQ-5D. Rotterdam, NL: EuroQol Group; 2004.
25. Harris WH: Traumatic arthritis of the hip after dislocation and acetabular
fractures: treatment by mold arthroplasty. JBJS 1969, 51A:737–755.
26. Rosenbaum PR, Rubin DB: The central role of the propensity score in
observational studies for causal effects. Biometrika 1983, 70:41.
27. D'Agostino RB Jr: Propensity score methods for bias reduction in the
comparison of a treatment to a non-randomized control group.
Stat Med 1998, 17:2265–2281.
28. Rubin DB: On principles for modeling propensity scores in medical
research. Pharmacoepidemiol Drug Saf 2004, 13:855–857.
29. Johnston AT, Barnsdale L, Smith R, Duncan K, Hutchison JD: Changes in
long-term mortality associated with fractures of the hip: evidence from
the Scottish hip fracture audit. JBJS Br 2010, 92B:989–993.
30. Butler M, Forte ML, Joglekar SB: Evidence summary: systematic review of
surgical treatments for geriatric hip fractures. JBJS 2011, 93:1104–1115.
31. Rahme E, Kahn SR, Dasgupta K, et al: Short-term mortality associated with
failure to receive home care after hemiarthroplasty. CMAJ 2010,
182:1421–1426.
32. Grigoryan K, Javedan H, Rudoph J: Ortho-geriatric care models and
outcomes in hip fracture patients: a systematic review and meta-analysis.
J Orthop Trauma 2013 [Epub ahead of print].
33. Friedman S, Mendelson D, Bingham K, et al: Impact of a comanaged
geriatric fracture center on short-term hip fracture outcomes. Arch Intern
Med 2009, 169:1712–1717.
34. Bhattacharyya R, Agrawal Y, Elphick H, et al: A unique orthogeriatic model:
a step forward in improving the quality of care for hip fracture patients.
Int J Surg 2013, 11:1083–1086.
35. Gohler A, Januzzi JL, Worrell SS, et al: A systematic meta-analysis of the
efficacy and heterogeneity of disease management programs in
congestive heart failure. J Card Fail 2006, 12:554–567.
36. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S: Effectiveness of
comprehensive disease management programmes in improving clinical
outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 2005,
7:1133–1144.
37. Whellan DJ, Hasselblad V, Peterson E, O'Connor CM, Schulman KA:
Metaanalysis and review of heart failure disease management
randomized controlled clinical trials. Am Heart J 2005, 149:722–729.
38. Yu DS, Thompson DR, Lee DT: Disease management programmes for
older people with heart failure: crucial characteristics which improve
post-discharge outcomes. Eur Heart J 2006, 27:596–612.
doi:10.1186/1754-9493-8-7
Cite this article as: Graham et al.: Reducing mortality in hip fracture
patients using a perioperative approach and “Patient- Centered Medical
Home” model: a prospective cohort study. Patient Safety in Surgery
2014 8:7.
